Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 3000

BillFederalSenateIn Committee
Patient Advocacy Transparency Act
About This Bill
Committee
Latest Action · June 6, 2018
Read twice and referred to the Committee on Finance.
Congress
115th (2017–2019)
Introduced
June 6, 2018
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
Patient Advocacy Transparency Act This bill expands the scope of transparency reports submitted by manufacturers of covered drugs, devices, and medical supplies under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.